Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation

Introduction: The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of vascular access 2021-05, Vol.22 (3), p.370-379
Hauptverfasser: Jiménez Hernández, Mario, Soriano, Alex, Filella, Xavier, Calvo, María, Coll, Elisenda, Rebled, Josep M, Poch, Esteban, Graterol, Fredzia, Compte, María Teresa, Maduell, Francisco, Fontsere, Néstor
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 379
container_issue 3
container_start_page 370
container_title The journal of vascular access
container_volume 22
creator Jiménez Hernández, Mario
Soriano, Alex
Filella, Xavier
Calvo, María
Coll, Elisenda
Rebled, Josep M
Poch, Esteban
Graterol, Fredzia
Compte, María Teresa
Maduell, Francisco
Fontsere, Néstor
description Introduction: The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions. Objective: To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response. Study design: This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal. Results: There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p 
doi_str_mv 10.1177/1129729820942040
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2425902953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1129729820942040</sage_id><sourcerecordid>2425902953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</originalsourceid><addsrcrecordid>eNp1kLtOwzAYhS0EoqWwMyGPLAHfEscjqrhUqsTSPbIdp3VJ7GInSH0CXhuHFgYkJl_OOd9vHwCuMbrDmPN7jIngRJQECUYQQydgijlhWYEoOU37JGejPgEXMW4RIiLH7BxMKCkELop8Cj4X3U7qHvoGtl6_WbeG0bdDb72L0DuovavteBoVZX1j2w42PnRyvITWwX5wzrStqeFGms7XVrb7aCPUst-Y3oQIpauTsWlll1I-7GEwcZf4BqbJ9uObdAnOGtlGc3VcZ2D19Liav2TL1-fF_GGZaUp5nwlCCce8JFxKhkuJa80KVVKpcqVzWtC85qWSzChS0JpimotGMWVobkST5Bm4PWB3wb8PJvZVZ6NOz5fO-CFWhJFcjDXRZEUHqw4-xmCaahdsJ8O-wqga26_-tp8iN0f6oDpT_wZ-6k6G7GCIcm2qrR-CS5_9H_gFjDuP1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425902953</pqid></control><display><type>article</type><title>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</title><source>MEDLINE</source><source>SAGE Journals Online</source><creator>Jiménez Hernández, Mario ; Soriano, Alex ; Filella, Xavier ; Calvo, María ; Coll, Elisenda ; Rebled, Josep M ; Poch, Esteban ; Graterol, Fredzia ; Compte, María Teresa ; Maduell, Francisco ; Fontsere, Néstor</creator><creatorcontrib>Jiménez Hernández, Mario ; Soriano, Alex ; Filella, Xavier ; Calvo, María ; Coll, Elisenda ; Rebled, Josep M ; Poch, Esteban ; Graterol, Fredzia ; Compte, María Teresa ; Maduell, Francisco ; Fontsere, Néstor</creatorcontrib><description>Introduction: The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions. Objective: To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response. Study design: This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal. Results: There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p &lt; 0.001), as was biofilm volume (1.01 ±1.18 vs 3.7 ± 2.15 vs 5.55 ±2.44, µm3, respectively; p &lt; 0.001). The mean interleukin-6 value was 39%, which was 50% lower than in the citrate and heparin groups, but without significance differences. Conclusion: Our results show that biofilms were found in all tunnelled cuffed catheters, but the thickness and volume were significantly lower in tunnelled cuffed catheters locked with taurolidine solution. Therefore, the type of locking solution used in tunnelled cuffed catheters should maintain tunnelled cuffed catheter sterility and prevent catheter-related bloodstream infections. No significant difference was observed in the inflammatory profile according to the type of locking solution.</description><identifier>ISSN: 1129-7298</identifier><identifier>EISSN: 1724-6032</identifier><identifier>DOI: 10.1177/1129729820942040</identifier><identifier>PMID: 32691665</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject><![CDATA[Adult ; Aged ; Aged, 80 and over ; Anti-Infective Agents - administration & dosage ; Anti-Infective Agents - adverse effects ; Anticoagulants - administration & dosage ; Anticoagulants - adverse effects ; Biofilms - drug effects ; Biofilms - growth & development ; Catheter-Related Infections - diagnosis ; Catheter-Related Infections - microbiology ; Catheter-Related Infections - prevention & control ; Catheters, Indwelling ; Citric Acid - administration & dosage ; Citric Acid - adverse effects ; Equipment Design ; Female ; Heparin - administration & dosage ; Heparin - adverse effects ; Humans ; Inflammation - blood ; Inflammation - etiology ; Inflammation - prevention & control ; Inflammation Mediators - blood ; Interleukin-6 - blood ; Male ; Microscopy, Confocal ; Microscopy, Electron, Scanning ; Middle Aged ; Pilot Projects ; Prospective Studies ; Renal Dialysis - adverse effects ; Renal Dialysis - instrumentation ; Surface Properties ; Taurine - administration & dosage ; Taurine - adverse effects ; Taurine - analogs & derivatives ; Thiadiazines - administration & dosage ; Thiadiazines - adverse effects ; Time Factors ; Treatment Outcome]]></subject><ispartof>The journal of vascular access, 2021-05, Vol.22 (3), p.370-379</ispartof><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</citedby><cites>FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</cites><orcidid>0000-0002-3704-7318</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1129729820942040$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1129729820942040$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21799,27903,27904,43600,43601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32691665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiménez Hernández, Mario</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Filella, Xavier</creatorcontrib><creatorcontrib>Calvo, María</creatorcontrib><creatorcontrib>Coll, Elisenda</creatorcontrib><creatorcontrib>Rebled, Josep M</creatorcontrib><creatorcontrib>Poch, Esteban</creatorcontrib><creatorcontrib>Graterol, Fredzia</creatorcontrib><creatorcontrib>Compte, María Teresa</creatorcontrib><creatorcontrib>Maduell, Francisco</creatorcontrib><creatorcontrib>Fontsere, Néstor</creatorcontrib><title>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</title><title>The journal of vascular access</title><addtitle>J Vasc Access</addtitle><description>Introduction: The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions. Objective: To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response. Study design: This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal. Results: There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p &lt; 0.001), as was biofilm volume (1.01 ±1.18 vs 3.7 ± 2.15 vs 5.55 ±2.44, µm3, respectively; p &lt; 0.001). The mean interleukin-6 value was 39%, which was 50% lower than in the citrate and heparin groups, but without significance differences. Conclusion: Our results show that biofilms were found in all tunnelled cuffed catheters, but the thickness and volume were significantly lower in tunnelled cuffed catheters locked with taurolidine solution. Therefore, the type of locking solution used in tunnelled cuffed catheters should maintain tunnelled cuffed catheter sterility and prevent catheter-related bloodstream infections. No significant difference was observed in the inflammatory profile according to the type of locking solution.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - administration &amp; dosage</subject><subject>Anti-Infective Agents - adverse effects</subject><subject>Anticoagulants - administration &amp; dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth &amp; development</subject><subject>Catheter-Related Infections - diagnosis</subject><subject>Catheter-Related Infections - microbiology</subject><subject>Catheter-Related Infections - prevention &amp; control</subject><subject>Catheters, Indwelling</subject><subject>Citric Acid - administration &amp; dosage</subject><subject>Citric Acid - adverse effects</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Heparin - administration &amp; dosage</subject><subject>Heparin - adverse effects</subject><subject>Humans</subject><subject>Inflammation - blood</subject><subject>Inflammation - etiology</subject><subject>Inflammation - prevention &amp; control</subject><subject>Inflammation Mediators - blood</subject><subject>Interleukin-6 - blood</subject><subject>Male</subject><subject>Microscopy, Confocal</subject><subject>Microscopy, Electron, Scanning</subject><subject>Middle Aged</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Renal Dialysis - adverse effects</subject><subject>Renal Dialysis - instrumentation</subject><subject>Surface Properties</subject><subject>Taurine - administration &amp; dosage</subject><subject>Taurine - adverse effects</subject><subject>Taurine - analogs &amp; derivatives</subject><subject>Thiadiazines - administration &amp; dosage</subject><subject>Thiadiazines - adverse effects</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1129-7298</issn><issn>1724-6032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOwzAYhS0EoqWwMyGPLAHfEscjqrhUqsTSPbIdp3VJ7GInSH0CXhuHFgYkJl_OOd9vHwCuMbrDmPN7jIngRJQECUYQQydgijlhWYEoOU37JGejPgEXMW4RIiLH7BxMKCkELop8Cj4X3U7qHvoGtl6_WbeG0bdDb72L0DuovavteBoVZX1j2w42PnRyvITWwX5wzrStqeFGms7XVrb7aCPUst-Y3oQIpauTsWlll1I-7GEwcZf4BqbJ9uObdAnOGtlGc3VcZ2D19Liav2TL1-fF_GGZaUp5nwlCCce8JFxKhkuJa80KVVKpcqVzWtC85qWSzChS0JpimotGMWVobkST5Bm4PWB3wb8PJvZVZ6NOz5fO-CFWhJFcjDXRZEUHqw4-xmCaahdsJ8O-wqga26_-tp8iN0f6oDpT_wZ-6k6G7GCIcm2qrR-CS5_9H_gFjDuP1Q</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Jiménez Hernández, Mario</creator><creator>Soriano, Alex</creator><creator>Filella, Xavier</creator><creator>Calvo, María</creator><creator>Coll, Elisenda</creator><creator>Rebled, Josep M</creator><creator>Poch, Esteban</creator><creator>Graterol, Fredzia</creator><creator>Compte, María Teresa</creator><creator>Maduell, Francisco</creator><creator>Fontsere, Néstor</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3704-7318</orcidid></search><sort><creationdate>202105</creationdate><title>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</title><author>Jiménez Hernández, Mario ; Soriano, Alex ; Filella, Xavier ; Calvo, María ; Coll, Elisenda ; Rebled, Josep M ; Poch, Esteban ; Graterol, Fredzia ; Compte, María Teresa ; Maduell, Francisco ; Fontsere, Néstor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-9232717827aa418a1dc46b83ab5bc53635d78ba4eb263d31359fb4be35e9f363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - administration &amp; dosage</topic><topic>Anti-Infective Agents - adverse effects</topic><topic>Anticoagulants - administration &amp; dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth &amp; development</topic><topic>Catheter-Related Infections - diagnosis</topic><topic>Catheter-Related Infections - microbiology</topic><topic>Catheter-Related Infections - prevention &amp; control</topic><topic>Catheters, Indwelling</topic><topic>Citric Acid - administration &amp; dosage</topic><topic>Citric Acid - adverse effects</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Heparin - administration &amp; dosage</topic><topic>Heparin - adverse effects</topic><topic>Humans</topic><topic>Inflammation - blood</topic><topic>Inflammation - etiology</topic><topic>Inflammation - prevention &amp; control</topic><topic>Inflammation Mediators - blood</topic><topic>Interleukin-6 - blood</topic><topic>Male</topic><topic>Microscopy, Confocal</topic><topic>Microscopy, Electron, Scanning</topic><topic>Middle Aged</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Renal Dialysis - adverse effects</topic><topic>Renal Dialysis - instrumentation</topic><topic>Surface Properties</topic><topic>Taurine - administration &amp; dosage</topic><topic>Taurine - adverse effects</topic><topic>Taurine - analogs &amp; derivatives</topic><topic>Thiadiazines - administration &amp; dosage</topic><topic>Thiadiazines - adverse effects</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiménez Hernández, Mario</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Filella, Xavier</creatorcontrib><creatorcontrib>Calvo, María</creatorcontrib><creatorcontrib>Coll, Elisenda</creatorcontrib><creatorcontrib>Rebled, Josep M</creatorcontrib><creatorcontrib>Poch, Esteban</creatorcontrib><creatorcontrib>Graterol, Fredzia</creatorcontrib><creatorcontrib>Compte, María Teresa</creatorcontrib><creatorcontrib>Maduell, Francisco</creatorcontrib><creatorcontrib>Fontsere, Néstor</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of vascular access</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiménez Hernández, Mario</au><au>Soriano, Alex</au><au>Filella, Xavier</au><au>Calvo, María</au><au>Coll, Elisenda</au><au>Rebled, Josep M</au><au>Poch, Esteban</au><au>Graterol, Fredzia</au><au>Compte, María Teresa</au><au>Maduell, Francisco</au><au>Fontsere, Néstor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation</atitle><jtitle>The journal of vascular access</jtitle><addtitle>J Vasc Access</addtitle><date>2021-05</date><risdate>2021</risdate><volume>22</volume><issue>3</issue><spage>370</spage><epage>379</epage><pages>370-379</pages><issn>1129-7298</issn><eissn>1724-6032</eissn><abstract>Introduction: The surface of tunnelled cuffed catheters provides an optimal environment for the development of biofilms, which have recently been described as conditioning films because of the presence of adherent biological materials. These biofilms are associated with infection and thrombosis and potentially increase patients’ inflammatory response. These complications could be reduced by the use of locking solutions. Objective: To analyse biofilm formation, using confocal and electron microscopy, in tunnelled cuffed catheters locked with three different solutions and to determine the relationship between these solutions and inflammatory response. Study design: This prospective study included 35 haemodialysis patients with tunnelled cuffed catheter removal for non–infection-related reasons. The participants were divided into three groups according to the lock solution used: (1) heparin 1: 5000 IU; (2) citrate 4%; and (3) taurolidine 1.35%, citrate 4% and heparin 500 IU (taurolock); in the latter group, 25,000 IU taurolidine–urokinase was used in the last weekly session. All tunnelled cuffed catheters were cultured, and the inner surface was evaluated with confocal and electron microscopy. The inflammatory profile of included patients was determined at tunnelled cuffed catheter removal. Results: There were no differences in clinical or demographic variables between the three subgroups. Biofilm thickness was lower in the taurolidine group than in the citrate 4% and heparin groups (28.85 ± 6.86 vs 49.99 ± 16.56 vs 56.2 ± 15.67 µm, respectively; p &lt; 0.001), as was biofilm volume (1.01 ±1.18 vs 3.7 ± 2.15 vs 5.55 ±2.44, µm3, respectively; p &lt; 0.001). The mean interleukin-6 value was 39%, which was 50% lower than in the citrate and heparin groups, but without significance differences. Conclusion: Our results show that biofilms were found in all tunnelled cuffed catheters, but the thickness and volume were significantly lower in tunnelled cuffed catheters locked with taurolidine solution. Therefore, the type of locking solution used in tunnelled cuffed catheters should maintain tunnelled cuffed catheter sterility and prevent catheter-related bloodstream infections. No significant difference was observed in the inflammatory profile according to the type of locking solution.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>32691665</pmid><doi>10.1177/1129729820942040</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3704-7318</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1129-7298
ispartof The journal of vascular access, 2021-05, Vol.22 (3), p.370-379
issn 1129-7298
1724-6032
language eng
recordid cdi_proquest_miscellaneous_2425902953
source MEDLINE; SAGE Journals Online
subjects Adult
Aged
Aged, 80 and over
Anti-Infective Agents - administration & dosage
Anti-Infective Agents - adverse effects
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Biofilms - drug effects
Biofilms - growth & development
Catheter-Related Infections - diagnosis
Catheter-Related Infections - microbiology
Catheter-Related Infections - prevention & control
Catheters, Indwelling
Citric Acid - administration & dosage
Citric Acid - adverse effects
Equipment Design
Female
Heparin - administration & dosage
Heparin - adverse effects
Humans
Inflammation - blood
Inflammation - etiology
Inflammation - prevention & control
Inflammation Mediators - blood
Interleukin-6 - blood
Male
Microscopy, Confocal
Microscopy, Electron, Scanning
Middle Aged
Pilot Projects
Prospective Studies
Renal Dialysis - adverse effects
Renal Dialysis - instrumentation
Surface Properties
Taurine - administration & dosage
Taurine - adverse effects
Taurine - analogs & derivatives
Thiadiazines - administration & dosage
Thiadiazines - adverse effects
Time Factors
Treatment Outcome
title Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A04%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20locking%20solutions%20on%20conditioning%20biofilm%20formation%20in%20tunnelled%20haemodialysis%20catheters%20and%20inflammatory%20response%20activation&rft.jtitle=The%20journal%20of%20vascular%20access&rft.au=Jim%C3%A9nez%20Hern%C3%A1ndez,%20Mario&rft.date=2021-05&rft.volume=22&rft.issue=3&rft.spage=370&rft.epage=379&rft.pages=370-379&rft.issn=1129-7298&rft.eissn=1724-6032&rft_id=info:doi/10.1177/1129729820942040&rft_dat=%3Cproquest_cross%3E2425902953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425902953&rft_id=info:pmid/32691665&rft_sage_id=10.1177_1129729820942040&rfr_iscdi=true